Columbus Prostate Cancer Center, LLC (CPCC) is a leading provider of radiation therapy treatment in Central Ohio. CPCC has operated in Columbus, Ohio since 2008 and provides a comfortable experience to prostate cancer patients while delivering the highest quality of care. Prior to the transaction, CPCC’s majority owner was Central Ohio Urology Group, Inc. (COUG), the largest urology practice in greater Columbus.

Founded in 2002, Vantage Oncology, LLC develops and operates radiation oncology centers of excellence through acquisitions and joint ventures. The company seeks to address the growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. Vantage Oncology currently operates 47 treatment facilities in 12 states.

As a result of the transaction, COUG and Vantage plan to grow high quality radiation therapy services in Central Ohio through a combination of strategic insight, application of clinical best-practices and a patient centered approach.

Cypress Associates LLC acted as financial advisor to CPCC in the sale of its assets to COUG and Vantage.